| Sort by: Article Title | Contributor | Topic | Date |
|---|---|---|---|
Marathon ManCEO Bill Steere says there is more to Pfizer than its little blue pill, which has already outstripped Prozac as the fastest selling drug in history. A strong focus on applied research and a formidable sales force has vaulted the company to within breathing distance of Merck. The question is, can Steere go the distance? |
JP Donlon | September 1 1998 | |
What’s Your Reputation Worth?Probably more than you suppose. With so much at risk, he care and feeding of corporate reputation, as distinct from brand image, is becoming a high priority for CEOs. In the following roundtable discussion CEOs examine how best to build and maintain reputational “equity:’ |
JP Donlon | July 1 1998 | |
Demanding Customers Make Good InnovatorsSpeed and relentless customer demands force CEOs to operate beyond their ‘comfort zone’ when it comes to pushing for new products and services. Surprisingly, a 29-year career AT&T veteran is very comfortable with that. |
JP Donlon | June 1 1998 | |
The Innovation MandateHaving a customer-focused process in place is important, but don’t overlook serendipity. If chance favors the prepared mind, unanticipated connections favor organizations ready to exploit them. |
JP Donlon | June 1 1998 | |
Primer Inter ParesEarlier this year we asked readers to identify a fellow CEO worthy to be named this year’s Chief Executive of [...] |
JP Donlon | June 1 1998 | |
The Great Innovation DebateImproving quality and slashing costs will not be sufficient for U.S. firms to hold their own in the global economy. Nor can the country’s position as an innovation leader be taken for granted. CE gathered business leaders and competitiveness scholar Michael Porter to examine steps CEOs need to take. |
JP Donlon | May 1 1998 | |
The P&G of PrisonsCCA, which ranks seventh in this year’s CE 100 growth index, has consistently ranked in the top 10 over the last three years. Corrections is hardly a glamorous industry and certainly not fashionably high-tech, so how does its CEO, doctor grants, get crime to pay so well-like 70 percent EPS growth since 1992? |
JP Donlon | May 1 1998 | |
Euro-Tunnel VisionFor years the elites who gather each year at Davos have been talking about the inevitability of a European common currency. With the January 1, 1999, deadline comes the hard part-can they make it work? |
JP Donlon | April 1 1998 | |
No Guts, No Global GloryGlobalization,” writes Jack Welch in his letter to shareholders in GE’s 1997 annual report, “is one of the engines of [...] |
JP Donlon | April 1 1998 | |
Fiat Looks For Its Global GearLong an international agglomerate with deep European roots. Fiat is expanding aggressively to be a transnational player in emerging markets from India to South America. What remains to be seen is whether CEO Paolo Cantarella and Chairman Paolo fresco can transform the management of Italy’s largest private enterprise accordingly. |
JP Donlon | April 1 1998 |